Clinical Trial Update: A Study of Pyridostigmine in Postural Tachycardia Syndrome [Phase 2]

View source ↗

Summary

This Mayo Clinic-sponsored Phase 2 trial is evaluating pyridostigmine for postural tachycardia syndrome and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postural Tachycardia Syndrome

Drugs mentioned

• Mestinon (pyridostigmine bromide)

Snippet

Sponsor: Mayo Clinic | Conditions: Postural Tachycardia Syndrome | Phase 2 | Status: RECRUITING